Medical Policy Updates

Notification of Policy Revisions Effective October 1, 2020 Posted July 28, 2020

Medical Policy Revision
Gamma-glutamyl Transferase AHS – G2173 "Notification" New policy developed. BCBSNC will provide reimbursement for gamma-glutamyl transferase when it is determined that the medical criteria and reimbursement guidelines are met. Medical Director review 7/2020. Policy noticed 7/28/20 for effective date 10/1/20.
Red Blood Cell Molecular Testing AHS-M2170 "Notification" New policy developed. BCBSNC will provide coverage for red blood cell molecular testing when it is determined that the medical criteria and guidelines are met. Medical Director review 7/2020. Policy noticed 7/28/20 for effective date 10/1/20.